arrow
L

Luis A. Díaz

Johns Hopkins University
H指数:124
被引数:11.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Exercise on Clonal Hematopoiesis
2025-10-010
OAAI
Nonoperative Management of Technically Resectable Pancreatic Cancer With Ablative Radiation Therapy

技术上可切除的胰腺癌采用消融放射治疗的非手术治疗管理

2025-04-101
PRE
Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study

帕博利珠单抗与化疗在微卫星高度不稳定或错配修复缺陷型转移性结直肠癌中的应用比较:随机III期KEYNOTE-177研究的5年随访结果

2025-03-016
PRE
Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy
2024-11-011
PRE
Advancing Global Health Equity in Oncology Clinical Trial Access
2024-09-240
PRE
Clonal Hematopoiesis Is Associated With Long-Term Adverse Outcomes Following Cardiac Surgery

克隆性造血与心脏手术后的长期不良结局相关

2024-09-031
PRE
Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings

使用从指甲剪下的DNA对血液系统恶性肿瘤患者进行通用种系基因检测

2024-04-042
OAAI
Shotgun sequencing of serial fecal microbiome samples in patients with colorectal cancer reveals distinct bacterial species and metabolic pathways associated with tumor sidedness and age at diagnosis
2024-03-220
PRE
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients
2024-03-0112
OAAI
Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the KEYNOTE-177 study Asia subgroup
2023-11-010
PRE
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade
2023-10-165
PRE